Replies to post #121940 on Anavex Life Sciences Corp (AVXL)

[blu_1]

MS w/Biogen dead and buried? Not so fast. Possibly no mention b/c Biogen isn't working on preclinical testing anymore. That is probably wrapped up. Now, possible out-licensing talks between Anavex and Biogen, hence why on slide 22 at bottom Anavex mentions "out-licensing" for first time ever. What could have prompted that? Perhaps someone (Biogen) is interested in Anavex's goods? If out-licensing for MS goes forward, development for that indication would appear on Biogen's Pipeline Overview, not Anavex's

[Steady_T]

The phase 1 trial was a safety and side effects trial. MMSE and the various other tests were not done so efficacy was not measured.